| 000 | 00965 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516121630.0 | ||
| 264 | 0 | _c20130524 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1744-8042 | ||
| 024 | 7 |
_a10.2217/pgs.12.140 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDuley, John A | |
| 245 | 0 | 0 |
_aThe future of thiopurine pharmacogenomics. _h[electronic resource] |
| 260 |
_bPharmacogenomics _cNov 2012 |
||
| 300 |
_a1549-52 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aAzathioprine _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMercaptopurine _xtherapeutic use |
| 650 | 0 | 4 |
_aMethyltransferases _xgenetics |
| 650 | 0 | 4 |
_aPharmacogenetics _xtrends |
| 650 | 0 | 4 |
_aThioguanine _xtherapeutic use |
| 700 | 1 | _aSomogyi, Andrew A | |
| 700 | 1 | _aMartin, Jennifer H | |
| 773 | 0 |
_tPharmacogenomics _gvol. 13 _gno. 14 _gp. 1549-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2217/pgs.12.140 _zAvailable from publisher's website |
| 999 |
_c22260811 _d22260811 |
||